Optimization of Fluid Therapy in Sepsis by a Passive Leg Raising Test
NCT ID: NCT02301585
Last Updated: 2016-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
34 participants
INTERVENTIONAL
2014-02-28
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: A passive leg raising test, will reduce weight gain by day 3 by 30%.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Restrictive Fluid Management on Cardiac Function and Glycocalyx Degradation
NCT04282252
Strong Albumin Solutions in Patients With Septic Shock
NCT05208242
Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock
NCT03762005
Physiological Effects of 38°C vs. 22°C Fluid Therapy in Critically Ill Patients
NCT04576806
A Randomized Controlled Trial of a Conservative Fluid Balance Strategy for Patients With Sepsis and Cardiopulmonary Dysfunction (BALANCE Study)
NCT02159079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Passive Leg Raising
Before decision on fluid administration a passive leg raising test is performed. If the test indicates fluid irresponsiveness optimization of circulation will be done with vasopressors or inotropes.
Passive Leg Raising Test
Before decision on fluid administration a passive leg raising test is performed. The results are interpreted according to a treatment protocol. If the test indicates fluid irresponsiveness optimization of circulation will be done with vasopressors or inotropes.
Standard of care
Patients are treated according to Surviving Sepsis Guidelines. Fluid is administered according to the choice of the clinician.
Standard of care
Patients are treated according to Surviving Sepsis Guidelines
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Passive Leg Raising Test
Before decision on fluid administration a passive leg raising test is performed. The results are interpreted according to a treatment protocol. If the test indicates fluid irresponsiveness optimization of circulation will be done with vasopressors or inotropes.
Standard of care
Patients are treated according to Surviving Sepsis Guidelines
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
Suspension criteria: The patient has developed pulmonary oedema during PLR test. Life threatening bleeding.
Serious adverse events:
Trombosis in arteria femoralis. Death during the study period.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Stockholm
OTHER_GOV
Svenska militärläkarföreningen
UNKNOWN
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christer Svensen
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christer Svensen, Prof
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska Institutet Södersjukhuset
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PLR EPN 2013/1337-31/2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.